Peter Schäfer

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Antonia Lopez‐Girona, Derek Mendy, Takumi Ito et al. · Leukemia · 2012 · 798 citations · Full text

Medicine, Oncology, Pharmacology +15

Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate <scp>T</scp> cells by inducing degradation of <scp>T</scp> cell repressors <scp>I</scp> karos and <scp>A</scp> iolos via modulation of the <scp>E</scp> 3 ubiquitin ligase complex <scp>CRL</scp> 4 <scp> ^CRBN </scp>

Anita K. Gandhi, Jian Kang, Courtney G. Havens et al. · British Journal of Haematology · 2013 · 621 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Prolonged Bacterial Culture to Identify Late Periprosthetic Joint Infection: A Promising Strategy

Peter Schäfer, Bernd Fink, D Sandow et al. · Clinical Infectious Diseases · 2008 · 545 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Undertreatment Strongly Decreases Prognosis of Breast Cancer in Elderly Women

Christine Bouchardy, Elisabetta Rapiti, G Fioretta et al. · Journal of Clinical Oncology · 2003 · 524 citations

Medicine, Geriatric Medicine, Oncology +16

Lenalidomide Enhances Natural Killer Cell and Monocyte-Mediated Antibody-Dependent Cellular Cytotoxicity of Rituximab-Treated CD20+ Tumor Cells

Lei Wu, Mary Adams, Troy Carter et al. · Clinical Cancer Research · 2008 · 434 citations · Full text

Life Sciences, Immunology, Pharmacology +17